No Data
Express News | Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Earnings Preview: ARQT to Report Financial Results Post-market on November 06
$Arcutis Biotherapeutics(ARQT.US)$ is scheduled to release its financial results post-market on November 06 ET. Earnings PreviewAnalysts estimate $Arcutis Biotherapeutics(ARQT.US)$ to post revenue
Arcutis Biotherapeutics, Inc. (ARQT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Arcutis Presents New Patient-Reported Outcome Data For ZORYVE Cream 0.15% In Atopic Dermatitis At American College Of Allergy, Asthma And Immunology 2024 Annual Scientific Meeting
Arcutis to Report Third Quarter 2024 Financial Results and Participate in an Upcoming Investor Conference
Buy Rating Reaffirmed for Arcutis Biotherapeutics Amid Temporary Challenges and Strong Zoryve Sales Forecast
No Data
No Data